FHIR Cross-Version Extensions package for FHIR R4B from FHIR R4
0.0.1-snapshot-2 - informative International flag

FHIR Cross-Version Extensions package for FHIR R4B from FHIR R4 - Version 0.0.1-snapshot-2. See the Directory of published versions

ValueSet: Cross-version VS for R4.v3.substanceAdminSubstitution for use in FHIR R4B

Official URL: http://hl7.org/fhir/4.0/ValueSet/R4-v3-substanceAdminSubstitution-for-R4B Version: 0.0.1-snapshot-2
Standards status: Informative Maturity Level: 0 Responsible: HL7 International / Terminology Infrastructure Computable Name: R4_v3_substanceAdminSubstitution_for_R4B

This cross-version ValueSet represents concepts from http://terminology.hl7.org/ValueSet/v3-substanceAdminSubstitution 2018-08-12 for use in FHIR R4B. Concepts not present here have direct equivalent mappings crossing all versions from R4 to R4B.

References

This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)

Logical Definition (CLD)

  • Include these codes as defined in http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution version 2018-08-12
    CodeDisplayDefinition
    BCbrand compositionSubstitution occurred or is permitted between equivalent Brands but not Generics

    *Examples:*

    * Zestril for Prinivil
    * Coumadin for Jantoven
    Ggeneric compositionSubstitution occurred or is permitted between equivalent Generics but not Brands

    *Examples:*

    * Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)
    ECequivalent compositionSubstitution occurred or is permitted with another product that is a:

    * pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester
    * pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration

    *Examples:*

    * *Pharmaceutical alternative:* Erythromycin Ethylsuccinate for Erythromycin Stearate
    * *Pharmaceutical equivalent:* Lisonpril for Zestril
    TBtherapeutic brandSubstitution occurred or is permitted between therapeutically equivalent Brands but not Generics

    >

    *Examples:*

    * Zantac for Tagamet
    TGtherapeutic genericSubstitution occurred or is permitted between therapeutically equivalent Generics but not Brands

    >

    *Examples:*

    * Ranitidine for cimetidine
    TEtherapeutic alternativeSubstitution occurred or is permitted with another product having the same therapeutic objective and safety profile.

    *Examples:*

    * ranitidine for Tagamet
    EequivalentSubstitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.
    FformularyThis substitution was performed or is permitted based on formulary guidelines.
    NnoneNo substitution occurred or is permitted.

 

Expansion

This value set expansion contains 9 concepts.

CodeSystemDisplayDefinition
  BChttp://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitutionbrand composition

Substitution occurred or is permitted between equivalent Brands but not Generics

Examples:

  • Zestril for Prinivil
  • Coumadin for Jantoven
  Ghttp://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitutiongeneric composition

Substitution occurred or is permitted between equivalent Generics but not Brands

Examples:

  • Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)
  EChttp://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitutionequivalent composition

Substitution occurred or is permitted with another product that is a:

  • pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester
  • pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration

Examples:

  • Pharmaceutical alternative: Erythromycin Ethylsuccinate for Erythromycin Stearate
  • Pharmaceutical equivalent: Lisonpril for Zestril
  TBhttp://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitutiontherapeutic brand

Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics

Examples:

  • Zantac for Tagamet
  TGhttp://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitutiontherapeutic generic

Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands

Examples:

  • Ranitidine for cimetidine
  TEhttp://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitutiontherapeutic alternative

Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile.

Examples:

  • ranitidine for Tagamet
  Ehttp://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitutionequivalent

Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.

  Fhttp://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitutionformulary

This substitution was performed or is permitted based on formulary guidelines.

  Nhttp://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitutionnone

No substitution occurred or is permitted.


Explanation of the columns that may appear on this page:

Level A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance)
Display The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code